SCHEMBL32688468

SCHEMBL32688468

CN(Cc1ccccc1)c1nc(=O)[nH]c(SCc2nnn[nH]2)c1C#N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAT2A P31153 1/20 0.42
▸ POLB P06746 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ CXCR2 P25025 1/20 0.36
▸ ACMSD Q8TDX5 2/20 0.35
▸ HSD11B1 P28845 2/20 0.35
▸ CTSB P07858 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ LMNA P02545 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ GPR55 Q9Y2T6 1/20 0.34
▸ RAPGEF4 Q8WZA2 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ CRHBP P24387 1/20 0.34
▸ CRHR2 Q13324 1/20 0.34
▸ GRM2 Q14416 1/20 0.33
▸ NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688258 0.81 HSD11B1 (0.38) POLBMEN1KMT2ACXCR2ACMSD
SCHEMBL32688366 0.79 ACMSD (0.47) POLBMEN1KMT2ACXCR2ACMSD
SCHEMBL32688260 0.76 CTSB (0.42) MAT2ACTSBMAPTPKM
SCHEMBL32688228 0.75 HSD11B1 (0.40) POLBMEN1KMT2ACXCR2HSD11B1
SCHEMBL32687964 0.74 MAT2A (0.50) MAT2APOLBCXCR2ALDH1A1LMNA
SCHEMBL32688253 0.73 CXCR2 (0.36) POLBMEN1KMT2ACXCR2
SCHEMBL32688114 0.72 CXCR2 (0.41) CXCR2ACMSDRAPGEF4PKM
SCHEMBL32688043 0.72 LMNA (0.45) POLBMEN1KMT2ACXCR2ACMSD
SCHEMBL32688407 0.72 ACMSD (0.39) POLBMEN1KMT2ACXCR2ACMSD
SCHEMBL32688388 0.71 KDM4E (0.33) MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK MAT2A 609/4885POLB 508/4885MEN1 4353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback